SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sanofi Discontinues Development of Nurix’s STAT6 Degrader SAR448272

The development decision is a narrow corporate update; the supplied body is truncated and gives no further details.

NRIX

Related stories